As we navigate an obesogenic environment and confront obesity as a complex disease, the continued development of therapeutics that target gut peptides and taste receptors will undoubtedly play a major role in the future of metabolic medicine
By acting on both GLP-1 and GIP receptors, Tirzepatide helps control blood sugar more broadly, stimulates insulin release, reduces glucagon release, slows down foods movement through the gut, and decreases appetite and food intake
Association of Testosterone Treatment With Alleviation of Depressive Symptoms in Men: A Systematic Review and Meta-analysis
Pigmentacja przez MC1R w kontekcie tego opisu oznacza obserwacj melanogeniczn w modelach i wczesnej literaturze, nie gwarancj bezpiecznego efektu kosmetycznego u czowieka
IGF-1 LR3 activates PI3K/Akt signaling downstream of the IGF-1 receptor, which translocates GLUT4 glucose transporters to cell membranes